FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pieter Zanen

Research Profile

Phenomena

Disorders

Chemicals & Drugs

Procedures

Activities & Behaviors

Smoking

Physiology

Pulmonary Diffusing Capacity

Concepts & Ideas

Devices

Nebulizers and Vaporizers

Co-author Network

Publications

TOP 3
Jessica van Setten; Max A Viergever; Cisca Wijmenga; Pieter Zanen; Pim A de Jong; Harry de Koning; Harry J M Groen; Ivana Isgum; Jan-Willem J Lammers; Willem P Th M Mali; H Marike Boezen; Matthijs Oudkerk; Dirkje S Postma; Stephan Ripke; Joanna Smolonska; Paul I W de Bakker
Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction.
Onno M Mets; Matthijs Oudkerk; Mathias Prokop; Bram van Ginneken; Pim A de Jong; Cas L J J Kruitwagen; Jan-Willem J Lammers; Pieter Zanen
CT Air Trapping Is Independently Associated with Lung Function Reduction over Time.
Firdaus A A Mohamed Hoesein; Dirkje S Postma; Joanna Smolonska; Els Wauters; Cisca Wijmenga; H Marike Boezen; Pim A de Jong; Marc Decramer; Harry J M Groen; Wim Janssens; Diether Lambrechts; Jan-Willem J Lammers; Pieter Zanen
Variants in the 15q24/25 locus associate with lung function decline in active smokers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pieter Zanen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jessica van Setten; Max A Viergever; Cisca Wijmenga; Pieter Zanen; Pim A de Jong; Harry de Koning; Harry J M Groen; Ivana Isgum; Jan-Willem J Lammers; Willem P Th M Mali; H Marike Boezen; Matthijs Oudkerk; Dirkje S Postma; Stephan Ripke; Joanna Smolonska; Paul I W de Bakker
Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction.
Atherosclerosis 2013;228(2):400-5.
2013: Onno M Mets; Matthijs Oudkerk; Mathias Prokop; Bram van Ginneken; Pim A de Jong; Cas L J J Kruitwagen; Jan-Willem J Lammers; Pieter Zanen
CT Air Trapping Is Independently Associated with Lung Function Reduction over Time.
PloS one 2013;8(4):e61783.
2013: Firdaus A A Mohamed Hoesein; Dirkje S Postma; Joanna Smolonska; Els Wauters; Cisca Wijmenga; H Marike Boezen; Pim A de Jong; Marc Decramer; Harry J M Groen; Wim Janssens; Diether Lambrechts; Jan-Willem J Lammers; Pieter Zanen
Variants in the 15q24/25 locus associate with lung function decline in active smokers.
PloS one 2013;8(1):e53219.
2012: Onno M Mets; Mathias Prokop; Bram van Ginneken; Pieter Zanen; Hester A Gietema; Ivana Isgum; Jan-Willem J Lammers; Pim A de Jong
Early identification of small airways disease on lung cancer screening CT: comparison of current air trapping measures.
Lung 2012;190(6):629-33.
2012: Firdaus A A Mohamed Hoesein; Dirkje S Postma; Bram van Ginneken; Pieter Zanen; H Marike Boezen; Pim A de Jong; Harry J M Groen; Jan-Willem J Lammers
Lung function decline in male heavy smokers relates to baseline airflow obstruction severity.
Chest 2012;142(6):1530-8.
2012: Onno M Mets; Christian P Mol; Mathias Prokop; Pieter Zanen; Hester A Gietema; Ivana Isgum; Pim A de Jong
Variation in quantitative CT air trapping in heavy smokers on repeat CT examinations.
European radiology 2012;22(12):2710-7.
2012: Firdaus A A Mohamed Hoesein; Mathias Prokop; Bram van Ginneken; Eva van Rikxoort; Pim A de Jong; Jan-Willem J Lammers; Pieter Zanen
Computed tomography-quantified emphysema distribution is associated with lung function decline.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2012;40(4):844-50.
2012: Firdaus A A Mohamed Hoesein; Alfred P E Sachs; Theo J M Verheij; Pieter Zanen; Jan-Willem J Lammers; Berna D L Broekhuizen
Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-dilator values?
COPD 2012;9(4):338-43.
2012: Gülmisal Güder; Matthias Held; Arno W Hoes; Jan-Willem Lammers; Christiane E Angermann; Susanne Brenner; Georg Ertl; Alfred P Sachs; Stefan Störk OR Stoerk; Pieter Zanen; Frans H Rutten
"GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study".
Respiratory research 2012;13(1):13.
2012: O M Mets; K Murphy; Mathias Prokop; Bram van Ginneken; Pieter Zanen; Hester A Gietema; Jan-Willem J Lammers; Pim A de Jong
The relationship between lung function impairment and quantitative computed tomography in chronic obstructive pulmonary disease.
European radiology 2012;22(1):120-8.
2011: Simona M Cristescu; Hester A Gietema; Frans J M Harren; C L J J Kruitwagen; J W J Lammers; P Munnik; R J van Klaveren; L Blanchet; L M C Buydens; Pieter Zanen
Screening for emphysema via exhaled volatile organic compounds.
Journal of breath research 2011;5(4):046009.
2011: F A A Mohamed Hoesein; B van Ginneken; Rob J van Klaveren; Pieter Zanen; J-W J Lammers
Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2011;38(5):1012-8.
2011: Onno M Mets; Matthijs Oudkerk; Mathias Prokop; Bram van Ginneken; Rob J van Klaveren; Rozemarijn Vliegenthart; Pieter Zanen; Harry J de Koning; Hester A Gietema; Ivana Isgum; Jan-Willem J Lammers; Willem P Th M Mali; Constantinus F M Buckens; Pim A de Jong
Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
JAMA : the journal of the American Medical Association 2011;306(16):1775-81.
2011: R G Keijsers; W J Oyen; Ewoudt M W van de Garde; Jules M M van den Bosch; E J Verzijlbergen; Pieter Zanen; Jan C Grutters
18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2011;28(2):123-9.
2011: Ingrid H E Korenromp; Jules M M van den Bosch; Pieter Zanen; Jan C Grutters; Annemieke Kavelaars; Cobi J Heijnen
Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue.
Brain, behavior, and immunity 2011;25(7):1498-502.
2011: Firdaus A A Mohamed Hoesein; Christian Mol; Dirkje S Postma; Mathias Prokop; Bram van Ginneken; Rob J van Klaveren; Pieter Zanen; H Marike Boezen; Bartjan de Hoop; Akkelies E Dijkstra; Hester A Gietema; Harry J M Groen; Ivana Isgum; Cas L J J Kruitwagen; Jan-Willem J Lammers
CT-quantified emphysema in male heavy smokers: association with lung function decline.
Thorax 2011;66(9):782-7.
2011: Firdaus A A Mohamed Hoesein; Pieter Zanen; Jan-Willem J Lammers
Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
Respiratory medicine 2011;105(6):907-15.
2011: Firdaus A A Mohamed Hoesein; Pieter Zanen; Jan-Willem J Lammers
Longitudinal change of prebronchodilator spirometric obstruction.
Thorax 2011;66(3):267-8; author reply 268-9.
2011: Elisabeth A Kastelijn; Karin M Kazemier; Johanna M Kwakkel-van Erp; Suzan M Roothaan; Henk Ruven; Ed A van de Graaf; Diana A van Kessel; C van moorsel; Pieter Zanen; Jan C Grutters
A genetic polymorphism in the CAV1 gene associates with the development of bronchiolitis obliterans syndrome after lung transplantation.
Fibrogenesis & tissue repair 2011;4():24.
2011: Marije Koopman; Pieter Zanen; Cas L J J Kruitwagen; Cornelis K van der Ent; H G M Arets
Reference values for paediatric pulmonary function testing: The Utrecht dataset.
Respiratory medicine 2011;105(1):15-23.
2010: F A A Mohamed Hoesein; Pieter Zanen
New concepts for expressing forced expiratory volume in 1 s: conclusions need nuances.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2010;36(3):693; author reply 694.
2010: Elisabeth A Kastelijn; Ger T Rijkers; C van moorsel; Pieter Zanen; Johanna M Kwakkel-van Erp; Ed A van de Graaf; Diana A Van Kessel; Jan C Grutters; Jules M M van den Bosch
Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010;29(9):997-1008.
2010: Elisabeth A Kastelijn; C van moorsel; Henk Ruven; Vincent Karthaus; Johanna M Kwakkel-van Erp; Ed A van de Graaf; Pieter Zanen; Diana A van Kessel; Jan C Grutters; Jules M M van den Bosch
Genetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010;29(6):680-6.
2010: Elisabeth A Kastelijn; C van moorsel; Ger T Rijkers; Henk Ruven; Vincent Karthaus; Johanna M Kwakkel-van Erp; Ed A van de Graaf; Pieter Zanen; Diana A van Kessel; Jan C Grutters; Jules M M van den Bosch
Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010;29(6):665-71.
2010: P Munnik; I van der Lee; J Fijn; L J van Eijsden; J-W J Lammers; Pieter Zanen
Comparison of eNO and histamine hyperresponsiveness in diagnosing asthma in new referrals.
Respiratory medicine 2010;104(6):801-7.
2010: Hester A Gietema; Pieter Zanen; Arnold Schilham; Bram van Ginneken; Rob J van Klaveren; Mathias Prokop; Jan-Willem J Lammers
Distribution of emphysema in heavy smokers: impact on pulmonary function.
Respiratory medicine 2010;104(1):76-82.
2009: Paul Munnik; Anne H de Boer; Jeroen Wissink; Paul Hagedoorn; Iwan Heskamp; Wilbur de Kruijf; Cees J M van Rijn; Henderik W Frijlink; Pieter Zanen
In vivo performance testing of the novel Medspray wet aerosol inhaler.
Journal of aerosol medicine and pulmonary drug delivery 2009;22(4):317-21.
2009: Jan Albert Vos; Gerrit J de Borst; Timotheus T C Overtoom; Jean-Paul P M de Vries; Eric D W M Van de Pavoordt; Pieter Zanen; R G A Ackerstaff
Carotid angioplasty and stenting: treatment of postcarotid endarterectomy restenosis is at least as safe as primary stenosis treatment.
Journal of vascular surgery 2009;50(4):755-761.e1.
2009: N P Barlo; C van moorsel; Henk Ruven; Pieter Zanen; Jules M M van den Bosch; Jan C Grutters
Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2009;26(2):155-61.
2009: Bartjan de Hoop; Hester A Gietema; Bram van Ginneken; Pieter Zanen; Gerard Groenewegen; Mathias Prokop
A comparison of six software packages for evaluation of solid lung nodules using semi-automated volumetry: what is the minimum increase in size to detect growth in repeated CT examinations.
European radiology 2009;19(4):800-8.
2008: T G W Letteboer; Hans-Jurgen Mager; Repke J Snijder; Dick Lindhout; Hans-Kristian Ploos van Amstel; Pieter Zanen; Kees J J Westermann
Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia.
American journal of medical genetics. Part A 2008;146A(21):2733-9.
2008: Anne H de Boer; Jeroen Wissink; Paul Hagedoorn; Iwan Heskamp; Wilbur de Kruijf; Ralf Bünder; Pieter Zanen; Paul Munnik; Cees van Rijn; Henderik W Frijlink
In vitro performance testing of the novel Medspray wet aerosol inhaler based on the principle of Rayleigh break-up.
Pharmaceutical research 2008;25(5):1186-92.
2008: M Weda; Pieter Zanen; Anne H de Boer; Dirk M Barends; Henderik W Frijlink
The therapeutic index of locally acting inhaled drugs as a function of their fine particle mass and particle size distribution: a literature review.
Current drug delivery 2008;5(2):142-7.
2008: Michiel Heron; WA Slieker; Pieter Zanen; Ellen G van Lochem; Herbert Hooijkaas; Jules M M van den Bosch; Heleen van Velzen-Blad
Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis.
Clinical immunology (Orlando, Fla.) 2008;126(3):338-44.
2008: Gerrit J de Borst; Pieter Zanen; Jean-Paul P M de Vries; Eric D W M Van de Pavoordt; R G A Ackerstaff; Frans L Moll
Durability of surgery for restenosis after carotid endarterectomy.
Journal of vascular surgery 2008;47(2):363-71.
2007: Ivo van der Lee; Pieter Zanen; Nadine Stigter; Jules M M van den Bosch; Jan-Willem J Lammers
Diffusing capacity for nitric oxide: reference values and dependence on alveolar volume.
Respiratory medicine 2007;101(7):1579-84.
2007: M M L Steeghs; Simona M Cristescu; P Munnik; Pieter Zanen; Frans J M Harren
An off-line breath sampling and analysis method suitable for large screening studies.
Physiological measurement 2007;28(5):503-14.
2006: Paul Munnik; Pieter Zanen; Jan-Willem J Lammers
A comparison of lung function equipment with emphasis on interchangeability and methods.
Physiological measurement 2006;27(6):445-55.
2006: Dick M Goedhart; Pieter Zanen; Jan-Willem J Lammers
Relevant and redundant lung function parameters in discriminating asthma from COPD.
COPD 2006;3(1):33-9.
2006: Ivo van der Lee; Pieter Zanen; Jan C Grutters; Repke J Snijder; Jules M M van den Bosch
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension.
Chest 2006;129(2):378-83.
2006: Ivo van der Lee; H W van Es; H J Noordmans; Jules M M van den Bosch; Pieter Zanen
Alveolar volume determined by single-breath helium dilution correlates with the high-resolution computed tomography-derived nonemphysematous lung volume.
Respiration; international review of thoracic diseases 2006;73(4):468-73.
2006: Ivo van der Lee; Pieter Zanen; Jules M M van den Bosch; Jan-Willem J Lammers
Pattern of diffusion disturbance related to clinical diagnosis: The K(CO) has no diagnostic value next to the DL(CO).
Respiratory medicine 2006;100(1):101-9.
2005: Dick M Goedhart; Pieter Zanen; Huib A M Kerstjens; Jan-Willem J Lammers
Discriminating asthma and COPD based on bronchodilator data: an improvement of the methods.
Physiological measurement 2005;26(6):1115-23.
2005: Ivo van der Lee; Pieter Zanen; Douwe H Biesma; Jules M M van den Bosch
The effect of red cell transfusion on nitric oxide diffusing capacity.
Respiration; international review of thoracic diseases 2005;72(5):512-6.
2005: Wim Gerritsen; Pieter Zanen; Anja A Bauwens; Jules M M van den Bosch; Fred J L M Haas
Validation of a new method to measure hydrogen peroxide in exhaled breath condensate.
Respiratory medicine 2005;99(9):1132-7.
2005: Pieter Zanen; Hans Folgering; Jan-Willem J Lammers
Flow-volumes indices as means to discriminate between intra- and extrapulmonary restrictive disease.
Respiratory medicine 2005;99(7):825-9.
2005: R G A Ackerstaff; Maarten J Suttorp; Jos C van den Berg; Timotheus T C Overtoom; Jan Albert Vos; Egbert T Bal; Pieter Zanen
Prediction of early cerebral outcome by transcranial Doppler monitoring in carotid bifurcation angioplasty and stenting.
Journal of vascular surgery 2005;41(4):618-24.
2005: Wim-Jan van Boven; Wim Gerritsen; Pieter Zanen; Jan C Grutters; H P A van Dongen; A Bernard; L P H J Aarts
Pneumoproteins as a lung-specific biomarker of alveolar permeability in conventional on-pump coronary artery bypass graft surgery vs mini-extracorporeal circuit: a pilot study.
Chest 2005;127(4):1190-5.
2005: Rob Janssen; Jan C Grutters; Hiroe Sato; Heleen van Velzen-Blad; Pieter Zanen; Nobuoki Kohno; Kenneth I Welsh; Roland M Du Bois; Jules M M van den Bosch
Analysis of KL-6 and SP-D as disease markers in bird fancier's lung.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2005;22(1):51-7.
2005: Wim Gerritsen; Jerryll Asin; Pieter Zanen; Jules M M van den Bosch; Fred J L M Haas
Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients.
Respiratory medicine 2005;99(1):84-90.
2004: M Weda; Pieter Zanen; Anne H de Boer; Dirk M Barends; Henderik W Frijlink
An investigation into the predictive value of cascade impactor results for side effects of inhaled salbutamol.
International journal of pharmaceutics 2004;287(1-2):79-87.
2004: Dick M Goedhart; Pieter Zanen; Jan-Willem J Lammers
Analyzing bronchodilation with emphasis on disease type, age and sex.
Controlled clinical trials 2004;25(6):563-71.
2004: Ivo van der Lee; Pieter Zanen
Diffusion capacity for nitric oxide and carbon monoxide.
Chest 2004;126(5):1708-9; author reply 1709-10.
2004: Rob Janssen; Jan C Grutters; Henk Ruven; Pieter Zanen; Hiroe Sato; Kenneth I Welsh; Roland M Du Bois; Jules M M van den Bosch
No association between interleukin-18 gene polymorphisms and haplotypes in Dutch sarcoidosis patients.
Tissue antigens 2004;63(6):578-83.
2003: Klaartje W Maas; Ivo van der Lee; K Bolt; Pieter Zanen; Jan-Willem J Lammers; Franz Schramel
Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment.
Lung cancer (Amsterdam, Netherlands) 2003;41(3):345-51.
2003: J G C van Amsterdam; Pieter Zanen; S Somer; Henk Van Loveren; Antoon Opperhuizen; Peter A Steerenberg
Flow dependency and off-line measurement of exhaled NO in children.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2003;14(4):266-71.
2002: Dick M Goedhart; Pieter Zanen
Selecting the best method to evaluate bronchodilation when analysing bronchodilator studies.
Statistics in medicine 2002;21(23):3677-85.
2002: M Weda; Pieter Zanen; Anne H de Boer; Doetie Gjaltema; A Ajaoud; Dirk M Barends; Henderik W Frijlink
Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy.
International journal of pharmaceutics 2002;249(1-2):247-55.
2002: Ivo van der Lee; Jules M M van den Bosch; Pieter Zanen
Reduction of variability of exhaled nitric oxide in healthy volunteers.
Respiratory medicine 2002;96(12):1014-20.
2002: Rob Janssen; M Weda; M B Ekkelenkamp; J-W J Lammers; Pieter Zanen
Metal versus plastic spacers: an in vitro and in vivo comparison.
International journal of pharmaceutics 2002;245(1-2):93-8.
2002: Johannes J Mager; Pieter Zanen; Fred Verzijlbergen; Cornelius J J Westermann; Tjeerd Haitjema; Gerard van Herk; Jan-Willem J Lammers
Quantification of right-to-left shunt with (99m)Tc-labelled albumin macroaggregates and 100% oxygen in patients with hereditary haemorrhagic telangiectasia.
Clinical science (London, England : 1979) 2002;102(2):127-34.
2001: Pieter Zanen; L van der Lee; T van der Mark; Jules M M van den Bosch
Reference values for alveolar membrane diffusion capacity and pulmonary capillary blood volume.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2001;18(5):764-9.
2001: Franz Schramel; Pieter Zanen
Blebs and/or bullae are of no importance and have no predictive value for recurrences in patients with primary spontaneous pneumothorax.
Chest 2001;119(6):1976-7.
2001: Marcel Th M van Rens; Pieter Zanen; Aart Brutel de la Rivière; HR Elbers; Henry A Van Swieten; Jules M M van den Bosch
Survival after resection of metachronous non-small cell lung cancer in 127 patients.
The Annals of thoracic surgery 2001;71(1):309-13.
2000: Marcel Th M van Rens; Pieter Zanen; Aart Brutel de la Rivière; HR Elbers; Henry A Van Swieten; Jules M M van den Bosch
Survival in synchronous vs. single lung cancer: upstaging better reflects prognosis.
Chest 2000;118(4):952-8.
2000: M Weda; E R Geuns; R C Vermeer; N R Buiten; K Hendriks-de Jong; A Bult; Pieter Zanen; Dirk M Barends
Equivalence testing and equivalence limits of metered-dose inhalers and dry powder inhalers measured by in vitro impaction.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;49(3):295-302.
1999: Pieter Zanen; J W Lammers
Reducing adverse effects of inhaled fenoterol through optimization of the aerosol formulation.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 1999;12(4):241-7.
1998: K A Boomars; R C Schweizer; Pieter Zanen; J M van den Bosch; J W Lammers; L Koenderman
Eosinophil chemotactic activity in bronchoalveolar lavage from idiopathic pulmonary fibrosis is dependent on cytokine priming of eosinophils.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1998;11(5):1009-14.
1998: Pieter Zanen; L T Go; Jan-Willem J Lammers
The efficacy of a low-dose, monodisperse parasympathicolytic aerosol compared with a standard aerosol from a metered-dose inhaler.
European journal of clinical pharmacology 1998;54(1):27-30.
1996: Pieter Zanen; L T Go; Jan-Willem J Lammers
Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction.
Thorax 1996;51(10):977-80.
1995: Pieter Zanen; Jan-Willem J Lammers
Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence.
European journal of clinical pharmacology 1995;48(3-4):179-84.
1994: René C Schweizer; B A Welmers; Jan A M Raaijmakers; Pieter Zanen; Jan-Willem J Lammers; Leo Koenderman
RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5.
Blood 1994;83(12):3697-704.
1991: H van der Kolk; Pieter Zanen; E Tushuizen; C F Gusdorf
The effect of inhalation flow on the performance of a dry powder inhalation system.
European journal of drug metabolism and pharmacokinetics 1991;Spec No 3():415-8.
1988: M Deenstra; Pieter Zanen; C F Gusdorf
Bronchospasmolytic effects of salbutamol as powder inhalation in patients with reversible bronchial obstruction.
Arzneimittel-Forschung 1988;38(10):1490-1.